TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 4 | 5 | 4 | 2 | -1 | -6 | -24 | -3 |
| S | %wins | 0 | 25 | 75 | 50 | 50 | 100 | 50 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/16/14 18:54 | 12/16/14 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Zein Youssef El | MA | D | S | -368 | 3.68 | 10 | -100 | -17 | 486 | D | 381 | 12 | 8 | 36 | 39 | 34 | -15 | -13 | 8 | 13 | 36 | 24 | 4 | -6 | |
3/18/09 12:45 | 3/16/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Zein Youssef El | MA | D | S | -250 | 5.62 | 0 | -44 | -8 | 511 | 2 | 3 | -3 | 4 | 17 | -24 | ||||||||||
1/14/09 16:31 | 1/12/09 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Zein Youssef El | MA | D | S.m | -287 | 8.42 | 0 | -34 | -6 | 555 | 8 | -4 | -20 | -25 | -32 | -37 | ||||||||||
12/24/08 14:44 | 12/22/08 | IDRA | Idera Pharmaceuticals, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Zein Youssef El | MA | D | S | -69 | 8.25 | 1 | -8 | -1 | 589 | D | 30 | -34 | -49 | -46 | -9 | 10 | -11 | -14 | 1 | 3 | -6 | -6 | -12 | -30 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |